Investigation on the ion pair amphiphiles and their in vitro release of amantadine drug based on PLGA–PEG–PLGA gel
Source abstract
Abstract
The amantadine drug and oleic acid surfactant are used to form amantadine-based ion pair amphiphiles based on proton transfer reaction between the drug and the surfactant molecules. The ion pair amphiphiles are characterized by 1H-nuclear magnetic resonance, Fourier transform infrared spectroscopy, and X-ray diffraction. Self-assembly properties of amantadine-based ion pair amphiphiles are studied by surface tension determination, transmission electron microscopy, zeta potential, and dynamic light scattering. The aggregation behavior studies indicate that the as-prepared ion pair amphiphiles can self-assemble into vesicles with the size of 200–300 nm in aqueous solution. The drug release results show that the amantadine release rate could be well controlled by incorporating the amantadine-based ion pair vesicles in poly (lactic-co-glycolic acid)-poly (ethylene glycol)-poly (lactic-co-glycolic acid) (PLGA–PEG–PLGA) copolymer hydrogel. The drug release from the AT–OA vesicle-loaded PLGA–PEG–PLGA hydrogel is significantly inhibited in comparison with the AT-loaded PLGA–PEG–PLGA hydrogel. The present work thus demonstrates that the vesicle-loaded hydrogel is a good candidate for the drug delivery system with long-term controlled drug release behavior.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Surfactants and Colloidal Systems · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818–182210.1126/science.1095833 ↗
2. Bamba M, Puisieux F, Marty JP, Carstensen JT (1979) Release mechanisms in gel-forming sustained release preparations. Int J Pharm 2:307–31510.1016/0378-5173(79)90037-1 ↗
3. Boudier A, Castagnos P, Soussan E, Beaune G (2011) Polyvalent catanionic vesicles: exploring the drug delivery mechanisms. Int J Pharm 403:230–23610.1016/j.ijpharm.2010.10.024 ↗
4. Cai X, Luan Y, Jiang Y, Song A, Shao W, Li Z, Zhao Z (2012) Huperzine A—phospholipid complex-loaded biodegradable thermosensitive polymer gel for controlled drug release. Int J Pharm 433:102–11110.1016/j.ijpharm.2012.05.009 ↗
5. Chakraborty H, Sarkar M (2004) Optical spectroscopic and TEM studies of catanionic micelles of CTAB/SDS and their interaction with a NSAID. Langmuir 20:3551–355810.1021/la0361417 ↗
6. Danhier F, Feron O, Préat V (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–14610.1016/j.jconrel.2010.08.027 ↗
7. Dash S, Murthy PN, Nath L, Chowdhury P (2010) Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 67(3):217–223
8. Discher DE, Eisenberg A (2002) Polymer vesicles. Science 297:967–97310.1126/science.1074972 ↗
9. Egli S, Nussbaumer MG, Balasubramanian V, Chami M, Bruns N (2011) Biocompatible functionalization of polymersome surfaces: a new approach to surface immobilization and cell targeting using polymersomes. J Am Chem Soc 133:4476–448310.1021/ja110275f ↗
10. Foley S, Enescu M (2007) A Raman spectroscopy and theoretical study of zinc-cysteine complexation. Vib Spectrosc 44(2):256–26510.1016/j.vibspec.2006.12.004 ↗
11. Gobble C, Rath N, Chickos J (2013) The vaporization enthalpies and vapor pressure of some primary amines of pharmaceutical importance by correlation gas chromatography. J Chem Eng Data 58:2600–260910.1021/je400498a ↗
12. Hao JC, Hoffmann H (2004) Self-assembled structures in excess and salt-free catanionic surfactant solutions. Curr Opin Colloid Interface Sci 9:279–29310.1016/j.cocis.2004.06.004 ↗
13. Hassan N, Ruso JM, Piñeiro Á (2011) Hydrogenated/fluorinated catanionic surfactants as potential templates for nanostructure design. Langmuir 27:9719–972810.1021/la2019346 ↗
14. Israelachvili JN, Mitchell DJ, Ninham BW (1976) Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers. J Chem Soc Faraday Trans 2(72):1525–156810.1039/f29767201525 ↗
15. Jackson RJ, Copper KL, Tappenden P (2011) Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review. J Infection 62:14–2510.1016/j.jinf.2010.10.003 ↗
16. Jiang Y, Li FF, Luan YX, Cao WT, Ji XQ, Zhao LX, Zhang LL, Li ZZ (2012) Formation of drug/surfactant catanionic vesicles and their application in sustained drug release. Int J Pharm 436:806–81410.1016/j.ijpharm.2012.07.053 ↗
17. Kaler EW, Murthy AK, Rodriguez BE, Zasadzinski JA (1989) Spontaneous vesicle formation in aqueous mixtures of single-tailed surfactants. Science 245:1371–137410.1126/science.2781283 ↗
18. Kampman KM, Dackis C, Lynch KG, Pettinatia H (2006) A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend 85:129–13710.1016/j.drugalcdep.2006.04.002 ↗
19. Kargi F, Dincer AR (1996) Effect of salt concentration on biological treatment of saline wastewater by fed-batch operation. Enzyme Microb Technol 19:529–53710.1016/S0141-0229(96)00070-1 ↗
20. Lin N, Huang J, Chang PR, Feng LD, Yu JH (2011) Effect of polysaccharide nanocrystals on structure, properties, and drug release kinetics of alginate-based microspheres. Colloids Surf B 85:270–27910.1016/j.colsurfb.2011.02.039 ↗
21. Mahmoud MB (2006) Impact of various salts on biology, physiology and tissue soluble proteins (SDS-PAGE) of Lymnaea natalensis and their infection with Fasciola gigantica miracidia. J Egypt Soc Parasitol 36(2):545–558
22. Monique D, Thadeus G, Bruno D, Thomas Z (1998) Rigid organic nanodisks of controlled size: a catanionic formulation. Comptes Rendus de l’Académie des Sciences - Series IIC - Chemistry 1:567–57510.1016/S1387-1609(98)80012-1 ↗
23. Omara HA, Amin AS (2012) Extractive-spectrophotometric methods for the determination of anti-Parkinsonian drug in pharmaceutical formulations and biological samples using sulphonphthalein acid dyes. J Saudi Chem Soc 16:75–8110.1016/j.jscs.2010.11.001 ↗
24. Qiao MX, Chen DW, Ma XW (2005) Injectable biodegradable temperature-responsive PLGA–PEG–PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels. Int J Pharm 294:103–11210.1016/j.ijpharm.2005.01.017 ↗
25. Ritger PL, Peppas NA (1987a) A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release 19:37–4210.1016/0168-3659(87)90035-6 ↗
26. Ritger PL, Peppas NA (1987b) A simple equation for description of solute release I Fickian and Non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1:23–2610.1016/0168-3659(87)90034-4 ↗
27. Romrell J, Fernandez HH, Okun MS (2003) Rationale for current therapies in Parkinson’s disease. Expert Opin Pharmacother 4:1747–176110.1517/14656566.4.10.1747 ↗
28. Sackmann E (1995) Physical basis of self-organization and function of membranes: physics of vesicles. Handb Biol Phys 1(5):21310.1016/S1383-8121(06)80022-9 ↗
29. Song Z, Feng R, Sun M, Guo C, Gao Y, Li L, Zhai G (2011) Curcumin-loaded PLGA–PEG–PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. J Colloid Interface Sci 354(1):116–12310.1016/j.jcis.2010.10.024 ↗
30. Soussan E, Cassel S, Blanzat M, Rico-Lattes I (2009) Drug delivery by soft matter: matrix and vesicular carriers. Angew Chem Int Ed Engl 48(2):274–28810.1002/anie.200802453 ↗
31. Talhout R, Engberts J (1997) Self-Assembly in mixtures of sodium alkyl sulfates and alkyltrimethylammonium bromides: aggregation behavior and catalytic properties. Langmuir 13(19):5001–500610.1021/la970388k ↗
32. Tran VT, Karam JP, Garric X, Coudane J, Benoît JP, Montero-Menei CN, Venier-Julienne MC (2012) Protein-loaded PLGA–PEG–PLGA microspheres: a tool for cell therapy. Eur J Pharm Sci 45:128–13710.1016/j.ejps.2011.10.030 ↗
33. Wang X, Danoff EJ, Sinkov NA, Lee JH (2006) Highly efficient capture and long-term encapsulation of dye by catanionic surfactant vesicles. Langmuir 22:6461–646410.1021/la0605135 ↗
34. Xu D, Cheng Q (2002) Surface-bound lipid vesicles encapsulating redox species for amperometric biosensing of pore-forming bacterial toxins. J Am Chem Soc 124:14314–1431510.1021/ja027897f ↗
35. Yokoyama M (2005) Drug targeting with nano-sized carrier systems. J Artif Organs 8:77–8410.1007/s10047-005-0285-0 ↗